Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with Type 2 diabetes: A Go-DARTS study
SLCO1B1 gene variants are associated with severe statin-induced myopathy. We examined whether these variants are also associated with general statin intolerance in a large population of patients with type 2 diabetes receiving statins as part of routine clinical care. A total of 4,196 individuals wer...
Main Authors: | Donnelly, L, Doney, A, Tavendale, R, Lang, C, Pearson, E, Colhoun, H, McCarthy, M, Hattersley, A, Morris, A, Palmer, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
by: Donnelly, L, et al.
Published: (2011) -
SLCO1B1 variants and statin-induced myopathy--a genomewide study.
by: Link, E, et al.
Published: (2008) -
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.
by: Zhou, K, et al.
Published: (2010) -
Creatine kinase and SLCO1B1 RS4363657 polymorphism in Malaysian dyslipidaemic patients prescribed with statin drugs
by: Meor Anuar Shuhaili, Meor Fairuz Rizal
Published: (2016) -
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
by: Zhou, K, et al.
Published: (2009)